Literature DB >> 25762480

Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study.

Pamela R Portschy1, Andrea M Abbott2, Erin E Burke1, Rumbidzayi Nzara1, Schelomo Marmor1, Karen M Kuntz3, Todd M Tuttle4.   

Abstract

PURPOSE: An increasing proportion of breast cancer patients undergo contralateral prophylactic mastectomy (CPM) to reduce their risk of contralateral breast cancer (CBC). Our goal was to evaluate CBC risk perception changes over time among breast cancer patients.
METHODS: We conducted a prospective, longitudinal study of women with newly diagnosed unilateral breast cancer. Patients completed a survey before and approximately 2 years after treatment. Survey questions used open-ended responses or 5-point Likert scale scoring (e.g., 5 = very likely, 1 = not at all likely).
RESULTS: A total of 74 women completed the presurgical treatment survey, and 43 completed the postsurgical treatment survey. Baseline characteristics were not significantly different between responders and nonresponders of the follow-up survey. The mean estimated 10-year risk of CBC was 35.7 % on the presurgical treatment survey and 13.8 % on the postsurgical treatment survey (p < 0.001). The perceived risks of developing cancer in the same breast and elsewhere in the body significantly decreased between surveys. Both CPM and non-CPM (breast-conserving surgery or unilateral mastectomy) patients' perceived risk of CBC significantly decreased from pre- to postsurgical treatment surveys. Compared with non-CPM patients, CPM patients had a significantly lower perceived 10-year risk of CBC (5.8 vs. 17.3 %, p = 0.046) on postsurgical treatment surveys.
CONCLUSIONS: The perceived risk of CBC significantly attenuated over time for both CPM and non-CPM patients. These data emphasize the importance of early physician counseling and improvement in patient education to provide women with accurate risk information before they make surgical treatment decisions.

Entities:  

Mesh:

Year:  2015        PMID: 25762480     DOI: 10.1245/s10434-015-4442-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

1.  Dose-dependent effect of mammographic breast density on the risk of contralateral breast cancer.

Authors:  Marzana Chowdhury; David Euhus; Maureen O'Donnell; Tracy Onega; Pankaj K Choudhary; Swati Biswas
Journal:  Breast Cancer Res Treat       Date:  2018-03-06       Impact factor: 4.872

2.  What does risk of future cancer mean to breast cancer patients?

Authors:  Karen Kaiser; Kenzie A Cameron; Jennifer Beaumont; Sofia F Garcia; Leilani Lacson; Margaret Moran; Lindsey Karavites; Chiara Rodgers; Swati Kulkarni; Nora M Hansen; Seema A Khan
Journal:  Breast Cancer Res Treat       Date:  2019-03-06       Impact factor: 4.872

3.  Barriers and Facilitators to De-Implementation of the Choosing Wisely® Guidelines for Low-Value Breast Cancer Surgery.

Authors:  Margaret E Smith; C Ann Vitous; Tasha M Hughes; Sarah P Shubeck; Reshma Jagsi; Lesly A Dossett
Journal:  Ann Surg Oncol       Date:  2020-03-02       Impact factor: 5.344

4.  Survey of the Deficits in Surgeons' Knowledge of Contralateral Prophylactic Mastectomy.

Authors:  Katharine Yao; Jeff Belkora; Mark Sisco; Shoshana Rosenberg; Isabelle Bedrosian; Erik Liederbach; Chihsiung Wang
Journal:  JAMA Surg       Date:  2016-04       Impact factor: 14.766

5.  Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status.

Authors:  Dadrie F Baptiste; Erina L MacGeorge; Maria K Venetis; Ashton Mouton; L Brooke Friley; Rebekah Pastor; Kristen Hatten; Janaka Lagoo; Susan E Clare; Monet W Bowling
Journal:  BMC Womens Health       Date:  2017-02-01       Impact factor: 2.809

6.  Prediction and clinical utility of a contralateral breast cancer risk model.

Authors:  Daniele Giardiello; Ewout W Steyerberg; Michael Hauptmann; Muriel A Adank; Delal Akdeniz; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Mariël Brinkhuis; Jenny Chang-Claude; Kamila Czene; Peter Devilee; Alison M Dunning; Douglas F Easton; Diana M Eccles; Peter A Fasching; Jonine Figueroa; Henrik Flyger; Montserrat García-Closas; Lothar Haeberle; Christopher A Haiman; Per Hall; Ute Hamann; John L Hopper; Agnes Jager; Anna Jakubowska; Audrey Jung; Renske Keeman; Iris Kramer; Diether Lambrechts; Loic Le Marchand; Annika Lindblom; Jan Lubiński; Mehdi Manoochehri; Luigi Mariani; Heli Nevanlinna; Hester S A Oldenburg; Saskia Pelders; Paul D P Pharoah; Mitul Shah; Sabine Siesling; Vincent T H B M Smit; Melissa C Southey; William J Tapper; Rob A E M Tollenaar; Alexandra J van den Broek; Carolien H M van Deurzen; Flora E van Leeuwen; Chantal van Ongeval; Laura J Van't Veer; Qin Wang; Camilla Wendt; Pieter J Westenend; Maartje J Hooning; Marjanka K Schmidt
Journal:  Breast Cancer Res       Date:  2019-12-17       Impact factor: 6.466

Review 7.  Is Mastectomy Oncologically Safer than Breast-Conserving Treatment in Early Breast Cancer?

Authors:  Fabian Riedel; André Hennigs; Sarah Hug; Benedikt Schaefgen; Christof Sohn; Florian Schuetz; Michael Golatta; Jörg Heil
Journal:  Breast Care (Basel)       Date:  2017-12-12       Impact factor: 2.860

8.  The risk of contralateral breast cancer: a SEER-based analysis.

Authors:  Vasily Giannakeas; David W Lim; Steven A Narod
Journal:  Br J Cancer       Date:  2021-05-26       Impact factor: 9.075

9.  Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely (®) Initiative.

Authors:  Jeffrey Landercasper; Lisa Bailey; Tiffany S Berry; Robert R Buras; Amy C Degnim; Oluwadamilola M Fayanju; Joshua Froman; Jennifer Gass; Caprice Greenberg; Starr Koslow Mautner; Helen Krontiras; Roshni Rao; Michelle Sowden; Judy A Tjoe; Barbara Wexelman; Lee Wilke; Steven L Chen
Journal:  Ann Surg Oncol       Date:  2016-06-22       Impact factor: 5.344

10.  Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).

Authors:  Kalatu R Davies; Abenaa M Brewster; Isabelle Bedrosian; Patricia A Parker; Melissa A Crosby; Susan K Peterson; Yu Shen; Robert J Volk; Scott B Cantor
Journal:  Breast Cancer Res       Date:  2016-09-20       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.